Order 120 mg Hysingla ER oral tablet extended release online


120 mg Hysingla ER oral tablet, extended release
from $3,386.20 for 60 tablets
QuantityPer unitPrice

Order 120 mg Hysingla ER oral tablet extended release online. Studies Show a randomized, double-blind, placebo-controlled study of individuals with uncontrolled moderate to severe persistent low back pain (LBP) for at least 3 months, an extended-release version of hydrocodone bitartrate (HYDRO ER) administered 20 to 120 mg once day provided effective analgesia over 12 weeks. There were no active comparable studies found.

Similar to oxycodone, fentanyl, and morphine, Hysingla ER (extended release) is a powerful, long-acting opioid pain medication. It binds to opioid receptors in the brain and spinal cord, which are found throughout the central nervous system. These receptors produce an analgesic (pain-relieving) action when they are engaged. Unlike other opioid drugs on the market, Hysingla ER’s effects can continue all day, making it appropriate for managing long-term severe pain.

Hysingla ER comes in the form of a tablet that dissolves over time, allowing for a slower release of hydrocodone into the bloodstream and fewer doses.

What is the indication for Hysingla ER treatment? Order 120 mg Hysingla ER oral tablet extended release online

Hysingla ER is an oral drug used to treat severe pain that requires treatment at all times of the day and night.

Hysingla ER is both safe and effective.

A research of 905 patients was done to compare the efficacy of Hysingla ER to a placebo. During a 45-day dose titration period, all patients were given the drug once a day (20 to 120 mg). 588 participants were found to have acceptable pain relief and tolerability and were included in a 12-week study comparing Hysingla ER versus placebo. 10% of patients stopped taking their medication at the end of the trial (5 percent of Hysingla patients and 15 percent of placebo patients). Furthermore, 5% of participants dropped out due to negative side effects (6 percent of Hysingla patients and 3 percent of placebo patients). When comparing Hysingla ER to placebo, patients experienced a 30 percent reduction in pain intensity.

Hysingla ER has several interesting information.

Hysingla ER is a controlled substance classified as a schedule II drug. It’s the first 24-hour oral extended-release hydrocodone formulation.
Unlike many other pain relievers on the market, this one contains hydrocodone without acetaminophen (Tylenol). The use of this medication lowers the risk of acetaminophen-induced liver damage in patients.
To get the same total daily quantity of hydrocodone, one Hysingla tablet taken once day is similar to taking Vicodin tablets 4 to 6 times daily.
When eaten, snorted, or injected, it is the first and only hydrocodone product with abuse-deterrent properties. It generates a viscous gel when crushed, fractured, or dissolved, making injection difficult.
The ER/LA Opioid Analgesics Risk Evaluation and Management Program presently includes this drug.

What is the Hysingla ER dose recommendation?

Hysingla ER comes in doses of 20, 30, 40, 60, 80, 100, and 120 mg in extended-release tablets. Patients who have never used opioids before should begin with a daily dose of 20 mg. Patients who have never taken an opioid medicine should not be given doses higher than 80 mg per day. To reach an appropriate level of pain relief, daily dosages should be modified in increments of 10 mg to 20 mg every three to five days.

To avoid opioid withdrawal symptoms such as anxiety, sweating, nausea, vomiting, and diarrhea, a gradual decrease in dose over 2-4 days is recommended when the medication is stopped.



There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.